DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $577,749 | -33.2% | 2,329 | -35.4% | 0.03% | -11.4% |
Q2 2023 | $864,887 | +15.3% | 3,604 | +21.1% | 0.04% | +6.1% |
Q1 2023 | $750,071 | -12.6% | 2,976 | -8.0% | 0.03% | -15.4% |
Q4 2022 | $858,368 | -13.9% | 3,234 | -16.2% | 0.04% | -13.3% |
Q3 2022 | $997,000 | -45.1% | 3,859 | -46.2% | 0.04% | -34.8% |
Q2 2022 | $1,817,000 | -54.4% | 7,167 | -47.2% | 0.07% | -56.9% |
Q1 2022 | $3,985,000 | -7.4% | 13,584 | +3.8% | 0.16% | -12.1% |
Q4 2021 | $4,305,000 | +10.3% | 13,085 | +2.0% | 0.18% | -7.1% |
Q3 2021 | $3,904,000 | +13.9% | 12,824 | +0.4% | 0.20% | +14.0% |
Q2 2021 | $3,427,000 | -54.2% | 12,769 | -61.6% | 0.17% | -57.7% |
Q1 2021 | $7,480,000 | -99.9% | 33,233 | -3.6% | 0.41% | -8.9% |
Q4 2020 | $7,657,166,000 | +786.6% | 34,470 | +759.4% | 0.45% | +698.2% |
Q3 2020 | $863,689,000 | +119524.5% | 4,011 | -1.8% | 0.06% | +600.0% |
Q2 2020 | $722,000 | +27.1% | 4,085 | -0.4% | 0.01% | -33.3% |
Q1 2020 | $568,000 | -20.7% | 4,101 | -12.1% | 0.01% | -20.0% |
Q4 2019 | $716,000 | +24.3% | 4,665 | +16.9% | 0.02% | +7.1% |
Q3 2019 | $576,000 | -3.0% | 3,990 | -4.0% | 0.01% | -6.7% |
Q2 2019 | $594,000 | +7.4% | 4,157 | -0.8% | 0.02% | -54.5% |
Q1 2019 | $553,000 | -15.8% | 4,189 | -34.3% | 0.03% | -25.0% |
Q4 2018 | $657,000 | +183.2% | 6,373 | +197.8% | 0.04% | +4300.0% |
Q3 2018 | $232,000 | – | 2,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |